[Brivaracetam for add-on treatment in focal epilepsy].
Strzelczyk A, Steinig I, Klein KM, Willems LM, Knake S, Rosenow F, Bauer S.
Nervenarzt · review; journal article · DOI 10.1007/s00115-016-0163-4 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för brivaracetam. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
25 hitsBrivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy.
Hoy SM.
CNS Drugs · review; journal article · DOI 10.1007/s40263-016-0376-xBrivaracetam (Briviact) for epilepsy.
Författaruppgift saknas
Med Lett Drugs Ther · journal articleBrivaracetam, lumacaftor/ivacaftor, and deoxycholic acid.
Hussar DA, George JR.
J Am Pharm Assoc (2003) · journal article · DOI 10.1016/j.japh.2016.06.001Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50-mg Film-Coated Tablet.
Otoul C, Watanabe S, McCabe S, Stockis A.
Clin Pharmacol Drug Dev · brief-report; research support, non-u.s. gov't; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1002/cpdd.275Bioavailability and bioequivalence comparison of brivaracetam 10, 50, 75, and 100 mg tablets and 100 mg intravenous bolus.
Stockis A, Hartstra J, Mollet M, Hadi S.
Epilepsia · research support, non-u.s. gov't; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1111/epi.13433Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.
Ben-Menachem E, Mameniškienė R, Quarato PP, Klein P, Gamage J, Schiemann J, Johnson ME, Whitesides J, McDonough B, Eckhardt K.
Neurology · clinical trial, phase iii; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.1212/wnl.0000000000002864Brivaracetam Population Pharmacokinetics and Exposure-Response Modeling in Adult Subjects With Partial-Onset Seizures.
Schoemaker R, Wade JR, Stockis A.
J Clin Pharmacol · clinical trial, phase iii; clinical trial, phase ii; randomized controlled trial; journal article · DOI 10.1002/jcph.761Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures.
Toledo M, Whitesides J, Schiemann J, Johnson ME, Eckhardt K, McDonough B, Borghs S, Kwan P.
Epilepsia · clinical trial, phase iii; clinical trial, phase ii; research support, non-u.s. gov't; multicenter study; journal article · DOI 10.1111/epi.13416Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy.
Klein P, Biton V, Dilley D, Barnes M, Schiemann J, Lu S.
Epilepsia · clinical trial, phase iii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1111/epi.13409Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison.
Zhang L, Li S, Li H, Zou X.
Seizure · meta-analysis; comparative study; journal article · DOI 10.1016/j.seizure.2016.05.004Emerging drugs for partial-onset epilepsy: a review of brivaracetam.
Gao L, Li S.
Ther Clin Risk Manag · research-article; journal article · DOI 10.2147/tcrm.s90127Schedules of Controlled Substances: Placement of Brivaracetam Into Schedule V. Interim final rule, with request for comments.
Drug Enforcement Administration, Department of Justice.
Fed Regist · journal articleBrivaracetam: new compound approved for the treatment of epilepsy.
Zaccara G.
Drugs Today (Barc) · review; journal article · DOI 10.1358/dot.2016.52.4.2480987Effect of Rifampin on the Disposition of Brivaracetam in Human Subjects: Further Insights into Brivaracetam Hydrolysis.
Stockis A, Watanabe S, Scheen AJ, Tytgat D, Gerin B, Rosa M, Chanteux H, Nicolas JM.
Drug Metab Dispos · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1124/dmd.115.069161Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
Strzelczyk A, Klein KM, Willems LM, Rosenow F, Bauer S.
Expert Rev Clin Pharmacol · review; journal article · DOI 10.1586/17512433.2016.1156529Brivaracetam add-on for refractory focal epilepsy: A systematic review and meta-analysis.
Lattanzi S, Cagnetti C, Foschi N, Provinciali L, Silvestrini M.
Neurology · meta-analysis; systematic review; journal article · DOI 10.1212/wnl.0000000000002545Brivaracetam: First Global Approval.
Markham A.
Drugs · review; journal article · DOI 10.1007/s40265-016-0555-6Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.
Klitgaard H, Matagne A, Nicolas JM, Gillard M, Lamberty Y, De Ryck M, Kaminski RM, Leclercq K, Niespodziany I, Wolff C, Wood M, Hannestad J, Kervyn S, Kenda B.
Epilepsia · research support, non-u.s. gov't; review; journal article · DOI 10.1111/epi.13340Brivaracetam for the treatment of epilepsy.
Klein P, Tyrlikova I, Brazdil M, Rektor I.
Expert Opin Pharmacother · review; journal article · DOI 10.1517/14656566.2016.1135129Stereochemistry of the Brivaracetam Diastereoisomers.
Qiu S, Tehrani KA, Sergeyev S, Bultinck P, Herrebout W, Mathieu B.
Chirality · research support, non-u.s. gov't; journal article · DOI 10.1002/chir.22558Erratum: Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures [Corrigendum].
Författaruppgift saknas
Drug Des Devel Ther · published erratum; correction · DOI 10.2147/dddt.s101194Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies.
Kälviäinen R, Genton P, Andermann E, Andermann F, Magaudda A, Frucht SJ, Schlit AF, Gerard D, de la Loge C, von Rosenstiel P.
Epilepsia · clinical trial, phase iii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1111/epi.13275Profile of brivaracetam and its potential in the treatment of epilepsy.
Ferlazzo E, Russo E, Mumoli L, Sueri C, Gasparini S, Palleria C, Labate A, Gambardella A, De Sarro G, Aguglia U.
Neuropsychiatr Dis Treat · review-article; review; journal article · DOI 10.2147/ndt.s60849Brivaracetam augments short-term depression and slows vesicle recycling.
Yang X, Bognar J, He T, Mohammed M, Niespodziany I, Wolff C, Esguerra M, Rothman SM, Dubinsky JM.
Epilepsia · journal article · DOI 10.1111/epi.13223